Reconstruction device and reconstruction method
By designing a reconstruction device including a base, carrier and bracket, using precisely defined mechanical processing and automated control, the problem of reliance on human factors in the traditional Chinese medicine restructuring in the prior art is solved, and the reconstruction efficiency and quality stability are improved sex.
Patent Information
- Application Number
- CN202080022417.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-03-21
- Filing Date
- 2020-03-16
- Publication Date
- 2024-11-08
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The prior art has artificial factors that rely on mechanical treatment in the process of reconstituting the agent, resulting in unstable quality and long reconstruction time, and may have potential deterioration effects on the agent.
A reconstructing device is designed, including a base, carrier and a movable bracket, to ensure that the agent container is reliably defined and highly reproducible through precisely defined mechanical treatments such as rotation, shaking and rolling. , and use drivers and controllers to achieve automated control.
The efficiency and quality stability of the remodeling of the agent is improved, the reconstruction time is reduced, and the risk of deterioration of the agent is reduced, achieving clearly defined and highly reproducible mechanical treatment.
Smart Images

Figure CN113597338B_ABST
Abstract
Description
[0001] The present disclosure relates to a reconstitution device operable and configured to prepare (ie, reconstitute) a liquid medicament. The present disclosure further relates to a method of reconstitute a medicament. Background Art
[0002] Certain disease states require treatment with one or more different medicaments. Some drug compounds need to be delivered in a specific relationship to deliver the optimal therapeutic dose. When delivering two active agents or "preparations" simultaneously, there are many potential problems. These two active preparations may interact during the long-term shelf life storage of the drug formulation. Therefore, it is advantageous to store the active ingredients separately and combine them when delivering (e.g., injection, needleless injection, pumping or suction). Before or during injection, the active ingredients must be properly mixed.
[0003] In addition, for some medicaments, the freeze-drying of protein formulations is a necessary tool for stability, and becomes increasingly important for pharmaceutical development. The reconstruction of freeze-dried pharmaceutical products, therefore the reconstruction of so-called freeze-dried cakes is crucial for obtaining a pharmaceutical product that can be applied. In order to reconstruct medicaments, liquid solvents or diluents are combined with freeze-dried products. This combination is then typically subjected to specific mechanical treatment, such as, shaking, twisting, rolling or stirring, until the medicine has been reconstructed or homogenized, and the content of the corresponding medicine container becomes applicable to use to the patient. Although this step affects the quality of the final solution, it is still a challenge to develop a standardized solution so far, because the mechanical treatment process is highly dependent on the human factor of the operator.
[0004] It would therefore be desirable to provide an improved reconstitution method and a device for reconstitute a medicament in a well-defined, reliable and safe manner. The overall time required to reconstitute a medicament should be reduced and any potential deteriorating effects on the medicament should be avoided or at least minimized. Summary of the invention
[0005] In one aspect, the present disclosure relates to a reconstitution device operable and / or configured to reconstitute a drug. The reconstitution device comprises a base and a carrier movably arranged on the base. The reconstitution device further comprises a support for a drug container. The support is movably arranged on the carrier.
[0006] The reconstitution device is operable to provide a well-defined, highly reproducible mechanical process, for example, the movement of a medication container when attached or fixed to the support. The support and therefore the medication container attachable to the support can be moved relative to the base about a first degree of mobility as defined by the movable arrangement of the carrier relative to the base. The support and the medication container can further be moved about a second degree of mobility as defined by the movable arrangement of the support on the carrier. Accordingly, the first degree of mobility and the second degree of mobility as defined by the movable carrier and as defined by the movable support can be different or can at least partially overlap.
[0007] In any case, since the support is movable relative to the carrier, and since the carrier is movable relative to the base, a rather complex but well-defined and highly reproducible movement of the medicament container relative to the base can be provided, which is beneficial for reconstitution of the medicament inside the medicament container.
[0008] In particular, the movable arrangement of the carrier on the base may comprise a constrained or positively driven mechanical guide. This may also be valid for the carrier being movably arranged on the base.
[0009] With the reconstitution device of the invention, the medication container can be movably arranged relative to the base in a dual manner. The movement of the support relative to the carrier can overlap with the movement of the carrier on the base. Thus, a first type of movement can overlap or can be combined with a second type of movement, wherein the first type of movement of the medication container is defined by the movable arrangement of the carrier on the base, and wherein the second type of movement of the medication container is defined by the movable arrangement of the support relative to the carrier.
[0010] According to another example, the carrier is rotatably mounted on the base. The carrier is rotatable relative to the base about a first rotation axis. The support for the medication container can be arranged on or at the carrier at a predetermined radial offset from the first rotation axis. In this way, the support and / or the medication container can be subjected to rotational movement relative to the base when the carrier rotates relative to the base. When the carrier is subjected to rotation relative to the base, this rotational movement can temporarily or permanently overlap with the movement of the support relative to the carrier.
[0011] For other examples, the bracket remains stationary on the carrier when the carrier is subjected to movement relative to the base. Here, many configurations are conceivable, according to which the bracket can be arranged at many or different positions on the carrier. For some examples, the bracket can be fixed to at least one of many available positions on the carrier. In this way, the position of the bracket on the carrier can be modified. During the rotation or movement of the carrier relative to the base, the bracket can remain stationary relative to the carrier. Therefore, the movable arrangement of the bracket on the carrier enables and provides a reconfigurable arrangement, positioning and reconfigurable fastening of the bracket on the movable carrier.
[0012] Instead of or in addition to the movable arrangement of the support on the carrier, the support can simply be reconfigurable and / or detachably fixed to the carrier. Here, the support can be detachable from one position of the carrier and can be attached to another position on the carrier. When the carrier is, for example, rotatably supported on the base, the radial distance of the support to the first rotation axis of the carrier can be modified. In this way, the centrifugal force present in the support and therefore applied to the medication container when the carrier is subjected to rotation relative to the base can be modified.
[0013] According to another example, the bracket is rotatably mounted on the carrier and is rotatable relative to the carrier about a second rotation axis. Here, the bracket itself is rotatably supported on the carrier. The first rotation axis and the second rotation axis may extend in parallel. The first rotation axis and the second rotation axis may extend at a predetermined angle relative to each other. For some examples, the second rotation axis extends at an angle substantially perpendicular to the direction of the first rotation axis.
[0014] With the reconfiguration device and during a reconfiguration process executable with the reconfiguration device, at least one of the carrier and the support is subjected to a movement relative to the base. For many examples, both the carrier and the support are simultaneously subjected to a movement relative to the base. Here, the carrier is subjected to a movement relative to the base and at the same time the support is subjected to a movement relative to the carrier. In this way, at least two movements can overlap, thus resulting in a well-defined combined and rather complex movement of the support relative to the base.
[0015] According to another example, the carrier comprises a rotating gantry. The rotating gantry is rotatably mounted on the base and is rotatable relative to the base about the first rotation axis. The rotating gantry may comprise a rotating table or a rotating disk rotatably supported about the first rotation axis.
[0016] According to a further example, the support is arranged or positioned on the rotating gantry. The support may be fixed to the rotating gantry. The support may be fixed on the rotating gantry in at least a first position and a second position, wherein the first position differs from the second position in a radial distance from the first axis of rotation. Thus, the support may be attached or may be arranged and fixed at many radial positions on the rotating gantry. The radial distance or radial position of the support on the rotating gantry relative to the first axis of rotation may be modified.
[0017] According to a further example, the support is longitudinally displaceable on the carrier. For example, when the carrier is rotationally supported on the base, the support is longitudinally displaceable in a radial direction about the first rotation axis. In this way, the radial distance between the support and the first rotation axis of the carrier can be modified. Simply by modifying the radial position of the support on the carrier relative to the first rotation axis, the centrifugal force that can be applied to the medicament container and therefore to the medicament located therein can be appropriately modified.
[0018] In another example, the reconfiguration device includes a first driver that is mechanically engaged with the carrier and configured to move the carrier relative to the base. Typically, the first driver includes an electric driver. The first driver is electrically operable to start and stop the movement of the carrier. Optionally, the first driver is electrically operable to control (i.e., change or modify) the speed of movement of the carrier relative to the base. Specifically, the first driver can be controlled by a controller. The controller can be programmed to activate, deactivate and / or control the first driver in a well-defined and highly reproducible manner.
[0019] According to another example, the reconfiguration device includes a second driver, which is mechanically engaged with the support and configured to move the support relative to the base. The second driver is arranged on one of the support and the carrier. The second driver is typically implemented as an electric driver. The second driver is typically connected to a controller (e.g., the programmable controller mentioned above) to start, stop and / or control the movement and movement speed of the support relative to the carrier.
[0020] The first driver and the second driver can be operated concurrently, alternately or simultaneously by the same controller. Alternatively, at least two separate controllers can be provided to separately control the first driver and the second driver. The first driver and the second driver enable or provide electronically controllable movement of the support relative to the carrier and / or relative to the base. In this way, a well-defined rotation, twisting, shaking, rolling or other mechanical movement of the medicine container relative to the base can be achieved. In fact, and as an advantage, the electronic control of at least one of the first driver and the second driver provides a fairly automated, reliable and highly reproducible reconstruction process for the medicine disposed inside the medicine container.
[0021] According to a further example, the reconfiguration device comprises a support arranged on the carrier. Furthermore, at least one of the support and the second drive is arranged on the support. In particular, the support may be a support that is longitudinally displaceable on the carrier. The support may provide and / or define the second axis of rotation. The support may be detachably connected to a plurality of fastening locations on the carrier that are spatially separated from one another. The support forms a base for the support. It may provide a bearing for a rotational movement of the support relative to the carrier.
[0022] For a further example, the support is longitudinally displaceable relative to the carrier. Furthermore, the support can be lockable to the carrier in one of a number of position states on the carrier. At least one of the support and the carrier comprises mutually corresponding fastening elements, by means of which the support can be locked to the carrier in any available position state. In this way, and when the carrier is implemented as a rotating gantry, the radial distance or radial position of the support and therefore of the bracket relative to the first rotation axis can be modified as required.
[0023] For another example, the reconfiguration device includes a first hinge, which is connected to the base and to the carrier. The first hinge includes a first hinge axis. The carrier is pivotable relative to the base about the first hinge axis. The first hinge may include a first hinge arm, which is pivotally connected to the base about the first hinge axis. The first hinge arm can provide support for the carrier. The carrier is typically mechanically connected to the first hinge arm. Specifically, the carrier is movably arranged on the first hinge arm. In other words, the carrier is mechanically connected to the base via the first hinge and via the first hinge arm. By pivoting the first hinge arm relative to the base, the orientation of the first rotation axis can be modified.
[0024] According to another example, the reconfiguration device includes a second hinge, which is connected to the support and to the carrier. The second hinge includes a second hinge axis. The support is pivotable relative to the carrier about the second hinge axis. The second hinge axis may include a second hinge arm that is pivotable relative to the carrier. For some examples, the second hinge is supported or integrated into the support. Here, the second hinge arm can be connected to the support, while another hinge component (such as a first hinge arm of the second hinge) is connected to or integrated into the support. With the second hinge, the orientation of the second axis of rotation can be modified relative to the orientation of the carrier.
[0025] According to another example, the first hinge axis extends at a non-zero angle with respect to the first rotation axis. Typically, the first hinge axis and the first rotation axis extend at a well-defined angle. The first hinge axis and the first rotation axis may extend at an angle of about 90°.
[0026] With respect to the first rotation axis, the first hinge axis may extend tangentially.In this way and by pivoting the carrier about the first hinge axis, the orientation of the first rotation axis may be modified relative to the base.
[0027] According to further examples, the second hinge axis extends at a non-zero angle with respect to the second rotation axis. Also here, the second hinge axis may extend at an angle of about 90° relative to the extension of the second rotation axis. Here, the second hinge axis may extend in a radial direction or in a tangential direction with respect to the second rotation axis. For some examples, the second rotation axis and the second hinge axis may intersect on or in one of the bracket and the support.
[0028] The pivot point or pivot axis defined by the second rotation axis may coincide with the second rotation axis.
[0029] This may also apply to the first hinge axis and the first rotation axis.However, for some embodiments, the first hinge axis is located at a predetermined radial distance from the first rotation axis.
[0030] For some examples and / or for some configurations of the reconfiguration device, the first rotation axis and the second rotation axis extend parallel to each other.For some examples and / or for some configurations of the reconfiguration device, the first hinge axis and the second hinge axis extend substantially parallel with respect to each other.
[0031] According to another example, the reconfiguration device includes a controller operable to control movement of the carrier relative to the base. Additionally or alternatively, the controller is operable to control movement of the support relative to the carrier. The controller is typically connected to at least one of the first drive and the second drive. The controller may include a microcontroller operable to perform preprogrammed activation and deactivation of at least one of the first drive and the second drive. In addition, the controller is operable to control and / or modify the speed of at least one of the first drive and the second drive.
[0032] According to another example, the reconstructing device includes a clamping device to removably fasten the medicine container to the support. The clamping device may include at least one or two movable clamping elements to mechanically engage with the medicine container and fasten the medicine container to the support. The clamping device may include three equidistantly arranged clamping elements, one of which is movable in a radial direction, for example, with respect to the tubular geometry of the medicine container. Typically, at least the movable clamping element is operably engaged with a reset element (such as a reset spring), which is operable to actuate the clamping element against the medicine container so as to fix and / or fasten the medicine container to the support by means of clamping.
[0033] The second rotation axis may extend through the support. The support may include a cylindrical geometry or cylindrical symmetry, wherein the second rotation axis serves as an axis of symmetry. For some examples, the plurality of clamping elements of the support are arranged equidistantly along the periphery of the tubular medication container.
[0034] The support and / or many of its fastening elements are configured to fasten the medicine container to the support with at least two different orientations or configurations. Typically, the medicine container comprises a planar bottom and a cylindrical sidewall. In one configuration, the medicine container is fastened or fixed to the support using three fastening elements that engage with the tubular sidewall of the medicine container. In a second and therefore different configuration, a fastening element in the fastening elements engages with the bottom of the medicine container, while the remaining (that is, at least two other) fastening elements mechanically engage opposite sections on the diameter of the sidewall of the medicine container. By arranging the medicine container on the support with at least two different orientations or configurations, the corresponding different and quite specific mechanical movement of the medicine container relative to the base can be provided according to a reconstruction plan or a reconstruction process.
[0035] In another example, the reconstitution device is equipped with a drug container. The drug container is fastened to the support. The drug container can be fastened to the support in one of at least two available fastening positions or fastening configurations. The drug container is typically provided with a lyophilized drug or agent. The interior space of the drug container is at least partially occupied by the firefly drug (i.e., the lyophilized cake).
[0036] The medicine container is further configured to receive a diluent or solvent. The medicine container typically includes at least one of an inlet or outlet sealed by a sealing cap. The sealing cap may include a pierceable septum that allows at least one of a diluent and a solvent to be supplied to the interior of the medicine container. The pierceable septum may include an elastomeric sealing disk or a rubber stopper fixed to the outlet portion of the container. The pierceable septum may be fixed to the outlet portion of the container by a corrugated metal cap, for example, made of aluminum. The medicine container may include a barrel made of a substantially inert material, such as plastic or glass. The medicine container may include a sidewall that is transparent to at least one spectral range of electromagnetic radiation. The medicine container may be transparent. It may be made of a vitreous material. The transparent material of the medicine container allows for visual inspection of the medicine and particularly of the reconstructed medicine located inside the medicine container.
[0037] In another aspect, the present disclosure further relates to a method for reconstructing a medicament. The method comprises the step of fastening a medicament container to a support of a reconstitution device as described above. The medicament container may be partially filled with a lyophilized medicament to be reconstituted. Typically, at least a portion of the medicament container is occupied by a lyophilized drug or medicament.
[0038] Before or after the drug container is fastened to the stent, the solvent or diluent required for the reconstitution of the drug will be added inside the drug container.
[0039] After the medicament container has been secured to the support, the carrier moves relative to the base and / or the support moves relative to the carrier. The movement of at least one of the carrier and the support is typically controlled by the controller and at least one of the first and second drives mechanically engaged with the carrier and the support, respectively.
[0040] Typically, the reconstitution method is program controlled. The method is typically performed by a preprogrammed controller. The controller is operable to activate and / or deactivate at least one of the first drive and the second drive so as to move the medicament container relative to the base and / or relative to the carrier in a well-defined manner within a predetermined time period.
[0041] The controller and thus the method can be implemented to perform a well-defined reconfiguration procedure. The reconfiguration procedure can include reconfiguration specific instructions, according to which the support for the medication container must move relative to the carrier and / or the base at a first speed within a first time period. Thereafter, the procedure can define that the support for the medication container must move in a different manner. The support can be subjected to a second type of movement at a second speed in a subsequent second time period. During many method steps, the speed and type of movement can be subjected to well-defined changes and / or modifications.
[0042] It should be further noted that any of the features, modes of operation, and benefits described above in connection with the reconstitution device are equally applicable to the method of reconstituted medicament; and vice versa.
[0043] As used herein, the term "drug" or "medicament" refers to a pharmaceutical formulation containing at least one pharmaceutically active compound.
[0044] In one embodiment, the pharmaceutically active compound has a molecular weight of up to 1500 Da, and / or is a peptide, protein, polysaccharide, vaccine, DNA, RNA, enzyme, antibody or antibody fragment, hormone or oligonucleotide, or a mixture of the above pharmaceutically active compounds,
[0045] Wherein in other embodiments, the pharmaceutically active compound can be used to treat and / or prevent diabetes or complications associated with diabetes (such as diabetic retinopathy), thromboembolic disease (such as deep vein or pulmonary thromboembolism), acute coronary syndrome (ACS), angina pectoris, myocardial infarction, cancer, macular degeneration, inflammation, hay fever, atherosclerosis and / or rheumatoid arthritis,
[0046] Wherein in another embodiment, the pharmaceutically active compound comprises at least one peptide for the treatment and / or prevention of diabetes or complications associated with diabetes (such as diabetic retinopathy),
[0047] In other embodiments, the pharmaceutically active compound includes at least one human insulin or human insulin analog or derivative, glucagon-like peptide (GLP-1) or an analog or derivative thereof, or exendin-3 or exendin-4, or an analog or derivative of exendin-3 or exendin-4.
[0048] Insulin analogs are, for example, Gly(A21), Arg(B31), Arg(B32) human insulin; Lys(B3), Glu(B29) human insulin; Lys(B28), Pro(B29) human insulin; Asp(B28) human insulin; human insulin in which the proline at position B28 is replaced by Asp, Lys, Leu, Val or Ala, and in which position B29 Lys may be replaced by Pro; Ala(B26) human insulin; Des(B28-B30) human insulin; Des(B27) human insulin and Des(B30) human insulin.
[0049] Insulin derivatives are, for example, B29-N-myristoyl-des(B30) human insulin; B29-N-palmitoyl-des(B30) human insulin; B29-N-myristoyl human insulin; B29-N-palmitoyl human insulin; B28-N-myristoylLysB28ProB29 human insulin; B28-N-palmitoyl-LysB28ProB29 human insulin; B30-N-myristoyl-ThrB2 9LysB30 human insulin; B30-N-palmitoyl-ThrB29LysB30 human insulin; B29-N-(N-palmitoyl-γ-glutamyl)-des(B30) human insulin; B29-N-(N-lithocholyl-γ-glutamyl)-des(B30) human insulin; B29-N-(ω-carboxyheptadecanoyl)-des(B30) human insulin and B29-N-(ω-carboxyheptadecanoyl) human insulin.
[0050] Exendin-4 refers, for example, to exendin-4 (1-39), a peptide having the following sequence: H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2.
[0051] The exendin-4 derivative is, for example, selected from the following list of compounds:
[0052] H-(Lys)4-des Pro36,des Pro37 exendin-4(1-39)-NH2,
[0053] H-(Lys)5-des Pro36,des Pro37 exendin-4(1-39)-NH2,
[0054] des Pro36 exendin-4 (1-39),
[0055] des Pro36[Asp28] exendin-4(1-39),
[0056] des Pro36[IsoAsp28] exendin-4(1-39),
[0057] des Pro36[Met(O)14,Asp28]exendin-4(1-39),
[0058] des Pro36[Met(O)14,IsoAsp28]exendin-4(1-39),
[0059] des Pro36[Trp(O2)25,Asp28]exendin-4(1-39),
[0060] des Pro36[Trp(O2)25,IsoAsp28]exendin-4(1-39),
[0061] des Pro36[Met(O)14Trp(O2)25,Asp28]exendin-4(1-39),
[0062] des Pro36[Met(O)14Trp(O2)25,IsoAsp28]exendin-4(1-39); or
[0063] des Pro36[Asp28] exendin-4(1-39),
[0064] des Pro36[IsoAsp28] exendin-4(1-39),
[0065] des Pro36[Met(O)14,Asp28]exendin-4(1-39),
[0066] des Pro36[Met(O)14,IsoAsp28]exendin-4(1-39),
[0067] des Pro36[Trp(O2)25,Asp28]exendin-4(1-39),
[0068] des Pro36[Trp(O2)25,IsoAsp28]exendin-4(1-39),
[0069] des Pro36[Met(O)14Trp(O2)25,Asp28]exendin-4(1-39),
[0070] des Pro36[Met(O)14Trp(O2)25,IsoAsp28]exendin-4(1-39),
[0071] The group -Lys6-NH2 can bind to the C-terminus of the exendin-4 derivative;
[0072] or an exendin-4 derivative having the following sequence:
[0073] des Pro36 exendin-4(1-39)-Lys6-NH2(AVE0010),
[0074] H-(Lys)6-des Pro36[Asp28] exendin-4(1-39)-Lys6-NH2,
[0075] des Asp28 Pro36,Pro37,Pro38 Exendin-4(1-39)-NH2,
[0076] H-(Lys)6-des Pro36,Pro38[Asp28]exendin-4(1-39)-NH2,
[0077] H-Asn-(Glu)5des Pro36,Pro37,Pro38[Asp28]exendin-4(1-39)-NH2,
[0078] des Pro36, Pro37, Pro38 [Asp28] exendin-4 (1-39) - (Lys) 6-NH2,
[0079] H-(Lys)6-des Pro36,Pro37,Pro38[Asp28] exendin-4(1-39)-(Lys)6-NH2,
[0080] H-Asn-(Glu)5-des Pro36,Pro37,Pro38[Asp28] exendin-4(1-39)-(Lys)6-NH2,
[0081] H-(Lys)6-des Pro36[Trp(O2)25,Asp28] exendin-4(1-39)-Lys6-NH2,
[0082] H-des Asp28 Pro36,Pro37,Pro38[Trp(O2)25]exendin-4(1-39)-NH2,
[0083] H-(Lys)6-des Pro36,Pro37,Pro38[Trp(O2)25,Asp28]exendin-4(1-39)-NH2,
[0084] H-Asn-(Glu)5-des Pro36,Pro37,Pro38[Trp(O2)25,Asp28]exendin-4(1-39)-NH2,
[0085] des Pro36, Pro37, Pro38 [Trp (O2) 25, Asp28] exendin-4 (1-39) - (Lys) 6-NH2,
[0086] H-(Lys)6-des Pro36,Pro37,Pro38[Trp(O2)25,Asp28] exendin-4(1-39)-(Lys)6-NH2,
[0087] H-Asn-(Glu)5-des Pro36,Pro37,Pro38[Trp(O2)25,Asp28] exendin-4(1-39)-(Lys)6-NH2,
[0088] H-(Lys)6-des Pro36[Met(O)14,Asp28] exendin-4(1-39)-Lys6-NH2,
[0089] des Met(O)14Asp28 Pro36,Pro37,Pro38 Exendin-4(1-39)-NH2,
[0090] H-(Lys)6-desPro36,Pro37,Pro38[Met(O)14,Asp28]exendin-4(1-39)-NH2,
[0091] H-Asn-(Glu)5-des Pro36,Pro37,Pro38[Met(O)14,Asp28]exendin-4(1-39)-NH2,
[0092] des Pro36, Pro37, Pro38 [Met (O) 14, Asp28] exendin-4 (1-39) - (Lys) 6-NH2,
[0093] H-(Lys)6-des Pro36,Pro37,Pro38[Met(O)14,Asp28] exendin-4(1-39)-(Lys)6-NH2,
[0094] H-Asn-(Glu)5des Pro36,Pro37,Pro38[Met(O)14,Asp28]exendin-4(1-39)-(Lys)6-NH2,
[0095] H-Lys6-des Pro36[Met(O)14,Trp(O2)25,Asp28]exendin-4(1-39)-Lys6-NH2,
[0096] H-des Asp28 Pro36,Pro37,Pro38[Met(O)14,Trp(O2)25]exendin-4(1-39)-NH2,
[0097] H-(Lys)6-des Pro36,Pro37,Pro38[Met(O)14,Asp28]exendin-4(1-39)-NH2,
[0098] H-Asn-(Glu)5-des Pro36,Pro37,Pro38[Met(O)14,Trp(O2)25,Asp28]exendin-4(1-39)-NH2,
[0099] des Pro36, Pro37, Pro38 [Met (O) 14, Trp (O2) 25, Asp28] exendin-4 (1-39) - (Lys) 6-NH2,
[0100] H-(Lys)6-des Pro36,Pro37,Pro38[Met(O)14,Trp(O2)25,Asp28] exendin-4(S1-39)-(Lys)6-NH2,
[0101] H-Asn-(Glu)5-des Pro36,Pro37,Pro38[Met(O)14,Trp(O2)25,Asp28]exendin-4(1-39)-(Lys)6-NH2;
[0102] Or a pharmaceutically acceptable salt or solvate of any of the above exendin-4 derivatives.
[0103] Hormones are, for example, pituitary hormones or hypothalamic hormones or regulatory active peptides as listed in Chapter 50 of the Rote Liste, 2008 edition, and their antagonists, such as gonadotropins (Follitropin, Luteinizing Hormone, Choriongonadotropin, Gametogenic Hormone), somatropine (Somatropin), desmopressin, terlipressin, gonadorelin, triptorelin, leuprorelin, buserelin, nafarelin, goserelin.
[0104] The polysaccharide is, for example, a glycosaminoglycan, hyaluronic acid, heparin, a low molecular weight heparin or an ultra-low molecular weight heparin or a derivative thereof, or a sulfated form (e.g., a polysulfated form) of the polysaccharide, and / or a pharmaceutically acceptable salt thereof. An example of a pharmaceutically acceptable salt of a polysulfated low molecular weight heparin is enoxaparin sodium.
[0105] Antibodies are globular plasma proteins (about 150 kDa), also called immunoglobulins, that share a basic structure. They are glycoproteins because of the addition of sugar chains to amino acid residues. The basic functional unit of each antibody is the immunoglobulin (Ig) monomer (containing only one Ig unit); secreted antibodies can also be dimers with two Ig units (such as IgA), tetramers with four Ig units (such as bony fish IgM), or pentamers with five Ig units (such as mammalian IgM).
[0106] The Ig monomer is a "Y" shaped molecule composed of four polypeptide chains; two identical heavy chains and two identical light chains are connected by disulfide bonds between cysteine residues. Each heavy chain is about 440 amino acids long; each light chain is about 220 amino acids long. The heavy and light chains each contain intrachain disulfide bonds that stabilize their folding. Each chain is composed of domains called Ig domains. These domains contain about 70-110 amino acids and are divided into different categories (such as variable regions or V regions and constant regions or C regions) based on their size and function. These domains have a characteristic immunoglobulin fold in which two beta folds are "sandwiched" together by interactions between conserved cysteines and other charged amino acids.
[0107] There are five types of mammalian Ig heavy chains, denoted α, δ, ε, γ, and μ. The type of heavy chain present defines the antibody's isotype; these chains are found in IgA, IgD, IgE, IgG, and IgM antibodies, respectively.
[0108] The different heavy chains vary in size and composition; α and γ contain about 450 amino acids, δ contains about 500 amino acids, and μ and ε contain about 550 amino acids. Each heavy chain has a constant region (C H ) and variable region (V H ) two regions. In one species, the constant region is essentially the same in all antibodies of the same isotype, but different in antibodies of different isotypes. Heavy chains γ, α, and δ have a constant region consisting of three tandem Ig domains, and a hinge region for increased flexibility; heavy chains μ and ε have a constant region consisting of four immunoglobulin domains. The variable region of the heavy chain is different in antibodies produced by different B cells, but is the same for all antibodies produced by a single B cell or B cell clone. The variable region of each heavy chain is about 110 amino acids long and consists of a single Ig domain.
[0109] In mammals, there are two types of immunoglobulin light chains, denoted by λ and κ. A light chain has two consecutive domains: a constant domain (CL) and a variable domain (VL). The approximate length of a light chain is 211 to 217 amino acids. Each antibody contains two light chains that are always identical; in mammals, only one type of light chain, κ or λ, exists for each antibody.
[0110] Although the general structure of all antibodies is very similar, the unique properties of a given antibody are determined by the variable (V) regions as detailed above. More specifically, the variable loops (three per light chain (VL) and three on the heavy chain (VH)) are responsible for binding to the antigen, i.e., for its antigen specificity. These loops are called complementarity determining regions (CDRs). Because the CDRs from the VH domain and the VL domain constitute the antigen binding site, it is the combination of the heavy and light chains (rather than each alone) that determines the final antigen specificity.
[0111] "Antibody fragments" contain at least one antigen-binding fragment as defined above, and exhibit essentially the same function and specificity as the complete antibody from which they are derived. Limited proteolysis with papain cleaves the Ig prototype into three fragments. Two identical amino-terminal fragments are antigen-binding fragments (Fab), each containing a complete L chain and about half of an H chain. The third fragment is a crystallizable fragment (Fc), which is similar in size but contains the carboxyl-terminal half of the two heavy chains and their interchain disulfide bonds. Fc contains carbohydrates, complement binding sites, and FcR binding sites. Limited pepsin digestion produces a single F(ab')2 fragment containing both the Fab segment and the hinge region, including the HH interchain disulfide bonds. F(ab')2 is divalent for antigen binding. The disulfide bonds of F(ab')2 can be cleaved to obtain Fab'. In addition, the variable regions of the heavy and light chains can be fused together to form a single-chain variable fragment (scFv).
[0112] Pharmaceutically acceptable salts are, for example, acid addition salts and basic salts. Acid addition salts are, for example, HCl salts or HBr salts. Basic salts are, for example, salts with cations selected from cations of alkali metals or alkaline earth metals, such as Na+ or K+ or Ca2+, or ammonium ions N+(R1)(R2)(R3)(R4), wherein R1 to R4 represent, independently of one another, hydrogen, optionally substituted C1-C6-alkyl groups, optionally substituted C2-C6-alkenyl groups, optionally substituted C6-C10-aryl groups, or optionally substituted C6-C10-heteroaryl groups. Other examples of pharmaceutically acceptable salts are described in the following documents: "Remington's Pharmaceutical Sciences" 17th edition Alfonso R. Gennaro (ed.), Mark Publishing Company, Easton, Pa., USA, 1985 and Encyclopedia of Pharmaceutical Technology.
[0113] Pharmaceutically acceptable solvates are, for example, hydrates.
[0114] It will also be clear to those skilled in the art that various modifications and variations may be made to the present invention without departing from the spirit and scope of the present invention. In addition, it should be noted that any reference numerals used in the appended claims should not be construed as limiting the scope of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0115] In the following, a number of examples of containers and injection devices will be described in more detail with reference to the accompanying drawings, in which:
[0116] Figure 1 An example of a reconstruction device is shown,
[0117] Figure 2 Shown from another perspective Figure 1 a reconstitution device wherein the housing is at least partially removed,
[0118] Figure 3 Shown through Figure 1 and Figure 2 The cross section of the reconstructed device,
[0119] Figure 4 Another configuration is shown Figure 1 The reconstruction device,
[0120] Figure 5 Another configuration is shown Figure 1 The reconstruction device,
[0121] Figure 6 A flow chart showing a method of operating a reconstruction device,
[0122] Figure 7 The stent of the reconstructive device is shown in more detail,
[0123] Figure 8 is through according to Figure 7 The cross section of the bracket,
[0124] Fig. 9 is another perspective view of the bracket in a radial position on the carrier, and
[0125] Fig.10 is another perspective view of the bracket at another radial position on the carrier. DETAILED DESCRIPTION
[0126] exist Figures 1 to 5 as well as Figures 7 to 10, many configurations of examples of a reconstruction device 10 are shown. The reconstruction device 10 includes a base 12. The base 12 can be stationarily located on a tabletop or any other type of support, such as a floor portion inside a building. The reconstruction device 10 further includes a carrier 20. The carrier 20 is movably arranged on the base 12. In the example currently shown, the carrier 20 is rotatably mounted on the base 12. The carrier rotates relative to the base 12 about a first rotation axis 14. In this regard, the carrier 20 can include a rotating gantry that rotates relative to the base 12 about the first rotation axis 14.
[0127] A support 30 for a medicine container 50 is movably arranged on the carrier 20. Typically, the medicine container 50 is at least partially filled with a medicine 51. The medicine 51 typically includes a lyophilized drug or a lyophilized pharmaceutical product. In order to reconstitute the medicine, a diluent or solvent may be provided inside the medicine container 50. The diluent or solvent may be added to the medicine 51 inside the medicine container 50 before or after the medicine container 50 is mounted (e.g., fixed or fastened) to the support 30.
[0128] like Figure 1 and Fig. 9 As shown, the support 30 may be provided with fastening means or clamping means 34 for removably fastening the medicament container 50 to the support 30 .
[0129] The bracket 30 is movably arranged on the carrier 20. Fig. 9 and Fig.10 It is clear from the comparison of the bracket 30 that the bracket 30 can be arranged and fastened to the carrier 20 in at least two different positions. For this purpose, the bracket 30 is provided with a support 80. The support 80 can be locked to the carrier 20 in many positions on the carrier 20. In the case of Fig.10 In the illustrated configuration, the support 80 is arranged relatively close to the first axis of rotation 14. Fig. 9 In the configuration, the support 80 and thus the holder 30 for the medicament container 50 is arranged at a radial distance from the first rotation axis 14, the radial distance being greater than Fig. 9 Thus, and by means of the support 80, the bracket 30 can be positioned and fixed to the carrier 20 in many position states. In this way, and with the rotatable carrier 20, the radial distance of the radial position of the bracket 30 with respect to the first rotation axis 14 can be modified.
[0130] The carrier 20 is rotatably supported on the base 12. Figure 3As shown, the carrier 20 is rotationally locked to a shaft 26, which is rotationally supported on the base 12. The shaft 26 is in torque-transmitting engagement with the driver 22. The driver 22 is implemented as an electric driver. The driver 22 can be controlled by a controller 90. The driver 22 and the shaft 26 are mechanically engaged by a gearbox 28 fastened to the base 12. For other examples, the shaft 26 can be directly rotationally engaged with the drive side or output end of the driver 22.
[0131] In either manner and by activating the drive 22, the carrier 20 may be rotationally moved relative to the base 12 about the first axis of rotation 14. The drive 22 is mounted on the base 12. The drive 22 and the gear box 28 may be pivotally mounted on the base 12.
[0132] By activating the drive 22 and by rotating the carrier 20 about the first axis of rotation 14 , a shaking-simulating movement of the holder 30 and of the medicament container 50 attached thereto can be achieved.
[0133] The reconstruction device 10 may further include a housing 5. The housing 5 may have a rectangular or cubic shape. Figures 1 to 5 As shown, the housing 5 comprises a top 4, two oppositely positioned side walls 8, a bottom 6 opposite the top 4, a front wall 7 and a rear wall 9. The rear wall 9 is positioned opposite the front wall 7.
[0134] The housing 5 may be displaceably mounted, for example, pivotally mounted on the base 12. A first hinge 60 may be provided, by means of which the housing 5 may be pivoted as a whole relative to the base 12 about a first hinge axis 62. The base 12 typically comprises a planar base plate. A first handle 15 may be provided that is attached or attached to one end of the base 12. An additional (i.e., second) handle 15 may be provided that is also attached or fixed to the base 12. The two handles 15 may be located at opposite ends of the base 12. With the help of the handle 15 and the base 12, the entire reconstitution device 10 can be easily transported from one place to another.
[0135] In order to securely and stably mount the reconstitution device 10, for example on a table, at least one fastener 16 may be provided, which extends through the base 12 or through a corresponding base plate. By means of the fastener 16, the base 12 may be immovably fastened to a support (e.g., a table). The fastener 16 may include a fastening screw.
[0136] The housing 5 is pivotally mounted on the base 12 about a first hinge axis 62. The first hinge axis 62 may substantially coincide with a corner section of the rear wall 9 and the bottom 6 of the housing 5. At least one stop 18 may be provided on the upper side of the base 12 at a predetermined distance from the rear wall 9 and outside the housing 5. The at least one stop 18 may protrude from the base 12. The at least one stop 18 provides a clearly defined stop for the pivoting movement of the housing 5 relative to the first hinge axis 62. Figure 5 In the illustrated configuration, in which the housing 5 has been rotated 90° about the first hinge axis 62, the rear wall 9 abuts against the at least one stop 18. A plurality of (at least two) stoppers 18 may be provided on the base 12 to prevent the housing 5 from being turned or pivoted as shown. Figure 5 The illustrated configuration provides for at least a two-fold abutment of the rear wall 9 . In this case, the first axis of rotation 14 extends substantially parallel to the plane of the base 12 .
[0137] A number of control elements 96, 98 are provided on the opposite front wall 7. By means of the control elements 98, the entire reconstitution device 10 can be opened and closed. The control elements 96 can be used to start and / or stop the movement of at least one of the carrier 20 and the support 30. For example, one of these control elements 96 can be operated to control the rotational movement of the carrier 20, wherein another control element 96 can be operated to control the rotational movement of the support 30. For each of these control elements 96, a visual indicator 95 can be provided, thus indicating whether the carrier 20 or the support 30 is in motion.
[0138] Further provided is a fastener 63, by means of which the pivoting movement of the housing 5 and / or the first hinge arm 61 of the hinge 60 can be fixed or blocked. The fastener 63 can include a cam lever 64, which allows the pivoting movement of the first hinge 16 to be fixed or released. In this way, it is also possible to obtain and / or maintain the housing 5 in a position such as Figure 1 The initial configuration shown is similar to Figure 5 An inclined position between the upright configurations shown. In such an inclined or tilted orientation of the housing 5 and / or the hinge arm 61 , the housing 5 can be fastened and / or fixed relative to the base 12 .
[0139] like Figure 1As further shown in , the carrier 20 comprises a rotating table located on the top of the housing 5. The carrier 20 may comprise a circular shape. The carrier is surrounded and limited in the radial direction by a frame 21. The frame 21 and the carrier 20 have substantially the same axial height or thickness about the first rotation axis 14. The frame 21 is immovably fixed to the top 4 and therefore to the first hinge arm 61. Specifically, the first hinge arm 61 and the rear wall 9 may be formed integrally. The immovable frame 21 provides protection for the movable carrier 20. By surrounding the frame 21, the movable part of the carrier 20 becomes substantially inaccessible from the outside.
[0140] like Figure 1 and Figure 5 As shown, a handle 23 is further provided on the top 4 of the housing 5. The handle 23 or handle bar extends beyond the front wall 7. It can be attached to the frame 21 or formed integrally with the frame. The handle 23 can be easily grasped by a user to cause a pivoting movement of the housing 5 and / or the hinge arm 61, for example to move the reconstitution device 10 from one side to another side. Figure 1 Configuration shown facing Figure 5 The configuration shown is transferred; and vice versa.
[0141] On the upper side of the carrier 20 facing away from the base 12, a support 80 is mounted displaceably in the radial direction with respect to the first axis of rotation 14. A sliding mechanism 82 may be provided, by means of which the support 80 is slidably displaceable at least with respect to the radial direction on the carrier 80. In this way, the radial position of the support 80 and the support 30 with respect to the first axis of rotation can be modified in a manner desired, for example, by a predetermined reconfiguration scenario.
[0142] The support 80 is movably connected to the carrier 20 by at least one slot link 81. The slot link 81 includes at least one elongated and straight groove 83. The groove 83 may be provided on the top of the carrier 20. The support 80 includes a correspondingly shaped pin slidably guided in the groove 83. For other embodiments, the support 80 is provided with an elongated groove, and the carrier 20 includes a correspondingly shaped pin slidably engaged with the groove of the support 80.
[0143] like Figures 7 to 10 As shown, the support 80 comprises a type of sliding bearing which is slidably displaceable along the extension of the groove 83. In the example shown, two parallel grooves are provided to constrain the movement of the support 80 relative to the bearing 20 in the radial direction about the first axis of rotation 14 and therefore along the extension of the groove 83.
[0144] A fastener 86 is further provided on at least one of the carrier 20 and the support 80. With the help of the fastener 86, the support 80 can be fixed in any available position state of the carrier 20. With the help of the slotted link 81, the support 80 can be continuously and / or steplessly moved along one or more grooves 83 on the top of the carrier 20.
[0145] like Fig.10 As further shown, at least one scale 84 is provided, which extends along at least one of the grooves 83 on the carrier 20. An indicator 85 is provided on the support 80, which is directly adjacent to the scale 84 and points to or onto the scale 84. The scale 84 can be provided with a number of symbols, numbers or the like, thus allowing the position of the support 80 along the slotted link 81 to be determined. In this way, the position of the support 80 on the carrier 20 can be accurately reproduced. Any available position state of the support 80 on the carrier 20 can be characterized by the position of the indicator 85 relative to the scale 84.
[0146] In addition to or in lieu of the sliding mechanism 82, the bracket 30 may also be rotatably supported on the carrier 20 about the second axis of rotation 24. The second axis of rotation 24 may be defined by the support 80 or any other bearing structure by which the bracket 30 is fastened or fixed to the carrier 20. Figures 1 to 3 In the illustrated configuration, the second rotation axis 24 extends obliquely or tilted to the first rotation axis 14. The second rotation axis 24 can substantially coincide with the axis of symmetry of the holder 30 and thus with the axis of symmetry of, for example, a tubular medicament container 50 which can be fastened to the holder 30. The holder 30 can be rotatably supported on the carrier 20 and in particular on the support 80 by means of a second drive 32. For this purpose, the support 80 comprises a rotary bearing 31, by means of which the holder 30 is rotatably supported on the support 80 and thus on the carrier 20.
[0147] The second drive 32 is typically implemented as an electric drive. It can be operated and / or controlled by a controller 90. The first drive 22 and the second drive 32 can be controlled by the same controller 90. For some examples, the first drive 22 can be coupled to the first controller 90. The second drive 32 can be coupled to a second controller, which is separate from the first controller 90. Therefore, at least two independent controllers can be provided for each of the first drive 22 and the second drive 32, respectively. A wire 92 that can electrically connect the second drive 32 and the controller 90 extends through the hollow shaft 26. A cable sleeve 94 that is rotationally invariant can be provided on or through the hollow shaft 26. In addition to or in place of a wire or cable connection, a sliding contact can also be provided between the controller 90 and at least one of the drives 22, 32. With the sliding contact, a rotationally invariant electrical connection can be provided at least between the controller 90 and the second drive 32. The sliding contact can be provided by one or more hollow slip rings. The controller 90 may further be equipped with an interface 91 enabling data to be transferred to and from the controller 90. In this way, the controller 90 may be pre-programmed according to a predetermined reconfiguration scheme.
[0148] By means of the first rotation axis 14 and the second rotation axis 24 and by means of the separate first drive 22 and the second drive 32, a combined rotational and circular motion of the support 30 and thus the medication container 50 can be provided. By means of the second drive 32 and the corresponding rotary bearing of the support 30 on the support 80, the medication container 50 can be rotated around its axis of symmetry. By means of the first drive 22, a type of stirring motion can be achieved. The directions of rotation of the support 30 and the carrier 20 can be the same or opposite to each other. The speeds of the carrier 20 and the support 30 can be the same or similar to each other. Alternatively and depending on a predetermined or preprogrammed reconstruction plan, the angular velocity of the carrier 20 relative to the base 12 and about the first rotation axis 14 is different from the angular velocity of the support 30 relative to the carrier 20 about the second rotation axis 24.
[0149] The rotational direction and / or angular velocity of the rotational movement of the carrier 20 and the support 30, as typically caused by the first and second drivers 22, 32, may be individually varied and controlled by the controller 90 according to a predetermined reconstruction plan or reconstruction procedure.
[0150] For the example of a reconfiguration procedure, during a first time interval, only one of the first driver 22 and the second driver 32 may be active. Thereafter and as a second step, both drivers 22, 32 may be activated and may be active during a second time period. During or after the second time period, at least one angular velocity of the support 30 and the carrier 20 may be subjected to a stepwise or gradual change.
[0151] like Fig. 9 and Fig.10 As further shown, the second rotation axis 24 can be tilted or pivoted relative to the first rotation axis 14. Thus, the support 30 can be pivoted relative to the carrier 20 by means of the second hinge 70. Figure 1 and Figures 8 to 10 The illustrated second hinge 70 comprises a second hinge axis 72. The second hinge 70 comprises a second hinge arm 71 pivotally mounted on a support 80. The second hinge arm 71 provides support for a swivel bearing 31 of the bracket 30. The position of the second hinge arm 71 can be fixed or locked relative to the support 80 in any available tilt or pivot position.
[0152] The second hinge axis 72 allows and supports the bracket 30 to pivot or rotate relative to the carrier 20. With the help of the second hinge 70, the bracket 30 can be moved from Figure 1 The upright configuration shown is rotated to a horizontal orientation, whereby the second axis of rotation 24 is flipped by 90°. Fig.10 , an intermediate configuration or orientation of the second rotation axis 24 is shown. Here, the second rotation axis 24 has been pivoted by approximately 45° compared to the first rotation axis 14.
[0153] With such an inclination, and by arranging the second axis of rotation 24 to be non-parallel to the first axis of rotation 14, a type of rocking motion of the support 30 and, therefore, the medication container 50 can be simulated when the carrier 20 is subjected to a continuous rotational movement relative to the base 12. To this end, the second drive 32 can be inoperable and can be turned off. The second hinge 70 can provide any stepped, discrete or continuous and, therefore, stepless pivoting or tilting of the support 30 relative to the carrier 20. In any available orientation or position, the second hinge 70 can be fixed, fastened or immobilized so as to maintain the tilted orientation of the support 30 or the medication container 50 relative to the carrier 20.
[0154] Typically, the second hinge axis 72 extends parallel to the planar upper surface of the carrier 20. The second hinge axis 72 may traverse or cross the second rotation axis 24. Specifically, the second hinge axis 72 may extend perpendicular to the second rotation axis 24.
[0155] In such Figure 4 and Figure 5In the illustrated further configuration, the carrier 20 may also undergo a tilting or pivoting movement relative to the base 12. As illustrated therein, the carrier 20 may be pivoted relative to the base 12 by a hinge 60 defining a first hinge axis 62. The first hinge axis 62 may also extend parallel to the surface of the planar carrier 20. The first hinge axis 62 is typically positioned radially offset from the first rotation axis 14. The first hinge axis 62 may extend in a tangential direction with respect to the first rotation axis 14.
[0156] like Figures 7 to 9 As further shown in FIG. 1 , the second hinge arm 71 may include a slightly U-shaped profile or shape. The second hinge arm 71 includes a substantially planar base portion 66 and a first wing 67 and a second wing 68 located on opposite sides of the base portion 66. The wings 67, 68 protrude substantially perpendicularly relative to the base portion 66 and protrude downwardly from the base portion 66. The second hinge arm 71 is pivotally mounted on the support 80 via the two wings 67, 68. Both wings 67, 68 intersect with the second hinge axis 72, as shown in FIG. Figure 8 At least one of the wings 67 , 68 is provided with a slot link 78 . The slot link 78 is located at a radial distance from the second hinge axis 72 .
[0157] The slot link 78 comprises a semicircular shape, the central axis of which coincides with the second hinge axis 72. The slot link 78 typically comprises a semicircular groove 73. A fastener 76 is further provided, which extends through the slot link 78 and thus through the groove 73. Figure 8 As shown, the fastener 76 can engage with a support element 88 of the support 80. The two wings 67, 68 are pivotally mounted on two oppositely positioned support elements 88, each of which protrudes upward from the upper surface of the support 80. The fastener 76 can include a fastening screw 77. The fastening screw 77 can include a thumb screw, by means of which the pivoting movement or tilting position of the bracket 30 relative to the support 80 about the second hinge axis 72 can be fixed and / or fastened. The release of the fastener 76 makes it possible to modify the orientation of the bracket 30 relative to the support 80 and / or relative to the carrier 20.
[0158] like Fig.10As further shown, one of the wings 67, 68 is provided with a scale 74 on the outer surface. The scale 74 comprises a semicircular shape and thus represents an angle scale. Adjacent to the scale 74, an indicator 75 is provided on the support element 88. The indicator 75, which for example comprises a pointed tip, points to the scale 74 and / or to said scale and thus indicates the angular position of the hinge 70. In this way, any angular position or tilted orientation of the bracket 30 and thus the second axis of rotation 24 relative to the support 80 can be accurately reproduced. The hinge 70 and thus the second hinge arm 71 can be pivoted steplessly and / or continuously relative to the support 80.
[0159] like Figure 4 As shown, the first hinge 60 comprises a first hinge arm 61 which is pivotable relative to the base 12 about a hinge axis 62. The first hinge arm 61 passes through and is connected to the base 12 via the first hinge 60.
[0160] exist Figures 8 to 10 In FIG. 1 , an example of a support 30 is shown in a horizontal section through the support 30, as seen from above. The support 30 comprises a clamping device 34. The clamping device 34 comprises three fastening elements 36, which can be arranged equidistantly around the periphery of the support 30 or the tubular medication container 50. The support 30 comprises a bottom 33, on which a tubular barrel 52 of, for example, a medication container 50 can be positioned. Typically, the barrel 52 has a tubular shape. It comprises, for example, Figures 8 to 10 The tubular side wall shown. The three fastening elements 36 are arranged equidistantly along the periphery along the circumferential direction of the barrel 52. At least one of the fastening elements 36 is provided with a movable fastener 38. Typically, the movable fastener 38 is movable in the radial direction about the second rotation axis 24. It can be slidably mounted in the bracket 30. The fastener 38 may include a fastening screw 40, which is, for example, implemented as a thumb screw that allows the user to operate easily and intuitively. The handle 40 can be moved radially outwardly relative to the bracket 30 about the tubular shape of the barrel 52. Optionally, the fastener 38 is mechanically coupled with a reset element (such as a reset spring), which is operable to radially inwardly actuate or retract the fastener to engage with the barrel 52 of the medicament container 50.
[0161] Each of the fastening elements 36 includes an abutment body 37 that can protrude radially inward from the corresponding fastening element 36. The abutment body 37 can include or can be made of an elastic material, such as an elastomeric material (e.g., a synthetic or natural rubber material). In this way, the barrel 52 of the medication container 50 can be mechanically fixed and locked to the bracket 30 with a friction force sufficient to fasten the medication container 50 to the bracket 30.
[0162] exist Figures 8 to 10 In the figure, only one of at least two different configurations for fastening and mounting the medicament container 50 to the bracket 30 is shown. Here, the bottom 54 of the medicament container 50 is engaged with the bottom 33 of the bracket 30, while the outside of the tubular barrel 52 is frictionally engaged with the fastening element 37. In another configuration (not shown), the bottom 54 of the medicament container 50 abuts against one of the fastening elements 36 in the radial direction, and the outside of the barrel 52, in particular the outside of the barrel side wall, is frictionally engaged with the other two fastening elements 36. Figures 1 to 10 Compared to the configuration shown in any of the figures, the medicine container 50 is flipped 90°.
[0163] In this way, and for example when the first hinge 60 has been pivoted 90° so that the first axis of rotation 14 is oriented substantially parallel to the bottom of the base 12 (eg Figure 5 ), the rotation of the carrier 20 relative to the base can simulate the flipping or twisting of the medication container 50. For this example and all other examples, the carrier 20 can be continuously pivoted or rotated in one direction or in an alternating manner (thus in a reversing manner).
[0164] However, this orientation of the medication container 50 may also be achieved by Figures 1 to 3 The arrangement of the medicament container 50 in the holder 30 shown in any of the figures is obtained when the first hinge 60 is rotated by 90° and when the second hinge 70 is also rotated by 90°. The second axis of rotation 24 can then extend substantially parallel to the planar surface of the carrier 20 .
[0165] exist Figure 6 , a flow chart of a method for reconstructing a medicament is briefly shown. In step 100, a medicament container is fastened to a support 30 of a reconstructing device 10 as described above. In a subsequent step 102, the carrier is moved relative to the base. In step 104, the support 30 is moved relative to the carrier 20 concurrently or simultaneously. For some examples of the method, the carrier and the support are moved by activating the corresponding first drive 22 and the second drive 32. The direction of movement or rotation and the speed and duration of movement or rotation can be changed during the reconstructing process according to a preprogrammed reconstructing step or reconstructing sequence. In the last step 106 and after the carrier 20 or the support 30 has been moved relative to the base 12 and / or relative to the carrier 20 for a predetermined time period, for example, defined by a predetermined reconstructing program, the method and therefore the movement of the carrier 20 and / or the support 30 will stop in step 106.
[0166] Reference numerals list
[0167] 4 Top
[0168] 5 Housing
[0169] 6 Bottom
[0170] 7 Anterior wall
[0171] 8 Sidewall
[0172] 9 Back wall
[0173] 10 Reconstruction device
[0174] 12 Base
[0175] 14 Axis of rotation
[0176] 15 Handle
[0177] 16 Fasteners
[0178] 18 Stopper
[0179] 20 Bearing
[0180] 21 Framework
[0181] 22 Driver
[0182] 23 Handle
[0183] 24 Rotation axis
[0184] 26 Axis
[0185] 28 Gear Box
[0186] 30 Bracket
[0187] 31 Swivel bearing
[0188] 32 Drivers
[0189] 33 Bottom
[0190] 34 Clamping device
[0191] 36 Fastening elements
[0192] 37 Adjacent body
[0193] 38 Fasteners
[0194] 40 Fastening screw
[0195] 50 Medicine Container
[0196] 51 Pharmacy
[0197] 52 tubes
[0198] 54 bottom
[0199] 60 Hinge
[0200] 61 hinge arm
[0201] 62 Hinge axis
[0202] 63 Fasteners
[0203] 64 Cam lever
[0204] 66 Base part
[0205] 67 Wing
[0206] 68 Wing
[0207] 70 Hinge
[0208] 71 hinge arm
[0209] 72 hinge axis
[0210] 73 Grooves
[0211] 74 Ruler
[0212] 75 Indicator
[0213] 76 Fasteners
[0214] 77 Fastening screw
[0215] 78 Slot Links
[0216] 80 Support
[0217] 81 Slot Links
[0218] 82 Sliding mechanism
[0219] 83 Grooves
[0220] 84 Ruler
[0221] 85 Indicator
[0222] 86 Fasteners
[0223] 87 Fastening screw
[0224] 88 Support element
[0225] 90 Controller
[0226] 91 Interface
[0227] 92 Wire
[0228] 94 Cable Sleeve
[0229] 95 Indicator
[0230] 96 Control elements
[0231] 98 Control elements
Claims
1. A reconstitution device for reconstructing a drug, the reconstitution device comprising: - a base (12), - a carrier (20) movably arranged on the base (12), a holder (30) for a medicament container (50), wherein the holder (30) is movably arranged on the carrier (20), - wherein the carrier (20) is rotatably mounted on the base (12) and is rotatable relative to the base (12) about a first axis of rotation (14), - wherein the support (30) is rotatably mounted on the carrier (20) and is rotatable relative to the carrier (20) about a second axis of rotation (24), and - wherein the second rotation axis (24) is tiltable or pivotable relative to the first rotation axis (14).
2. The reconstitution device according to claim 1, wherein the support (30) is movable relative to the base (12) about a first degree of movement defined by the movable arrangement of the carrier (20) relative to the base (12).
3. The reconstitution device according to claim 1, wherein the support (30) is movable about a second degree of movement defined by a movable arrangement of the support (30) on the carrier (20).
4. The reconstitution device according to claim 2, wherein the support (30) is movable about a second degree of movement defined by a movable arrangement of the support (30) on the carrier (20). 5 . The reconstruction device according to claim 4 , wherein the first degree of mobility and the second degree of mobility are different, or wherein the first degree of mobility and the second degree of mobility at least partially overlap.
6. The reconstitution device according to any one of claims 1 to 5, wherein the carrier (20) comprises a rotating gantry, and wherein the support (30) can be arranged at many or different positions on the carrier (20).
7. The reconstruction device according to any one of claims 1 to 5, wherein the support (30) is longitudinally displaceable on the carrier (20).
8. The reconstruction device according to any one of claims 1 to 5, further comprising a first actuator (22) mechanically engaged with the carrier (20) and configured to move the carrier relative to the base (12).
9. The reconstruction device according to claim 8, wherein the first drive (22) is an electric drive and is operable to control the speed of movement of the carrier (20) relative to the base (12).
10. The reconstruction device according to any one of claims 1 to 5, further comprising a second actuator (32) mechanically engaged with the support (30) and configured to move the support (30) relative to the carrier (20).
11. The reconstruction device according to claim 10, wherein the second drive (32) is an electric drive and is operable to control at least one of the start, stop and movement speed of the movement of the support (30) relative to the carrier (20).
12. The reconstruction device according to claim 10, further comprising a support (80) arranged on the carrier (20), and wherein at least one of the bracket (30) and the second driver (32) is arranged on the support (80).
13. The reconstruction device according to claim 12, wherein the support (80) is longitudinally displaceable relative to the carrier (20), and wherein the support (80) can be locked to the carrier (20) in a plurality of position states on the carrier (20).
14. Reconstruction device according to claim 12 or 13, wherein the support element (80) is detachably connected to a plurality of fastening locations on the carrier (20) which are spatially separated from one another.
15. The reconstitution device according to claim 12 or 13, wherein a radial distance or a radial position of the support (80) on the carrier (20) relative to the first axis of rotation (14) is modifiable.
16. The reconstruction device according to any one of claims 1-5, further comprising a first hinge (60) connected to the base (12) and to the carrier (20), wherein the first hinge (60) comprises a first hinge axis (62), and wherein the carrier (20) is pivotable relative to the base (12) about the first hinge axis (62).
17. A reconstruction device according to any one of claims 1-5, further comprising a second hinge (70) connected to the support (30) and to the carrier (20), wherein the second hinge (70) comprises a second hinge axis (72), and wherein the support (30) is pivotable relative to the carrier (20) about the second hinge axis (72).
18. The reconfiguration device of claim 16, wherein the first hinge axis (62) extends at a non-zero angle with respect to the first rotation axis (14).
19. The reconfiguration device of claim 17, wherein the second hinge axis (72) extends at a non-zero angle with respect to the second rotation axis (24).
20. The reconstruction device according to any one of claims 1-5, further comprising a controller (90), which is operable to control the movement of the carrier (20) relative to the base (12) and / or is operable to control the movement of the support (30) relative to the carrier (20).
21. The reconstitution device according to any one of claims 1 to 5, further comprising a drug container (50) fastened to the support (30).
22. The reconstitution device according to any one of claims 1 to 5, further comprising a clamping device (34) for removably fastening the drug container (50) to the support (30).
23. A method of reconstructing a pharmaceutical agent (51), the method comprising the steps of: - fastening the medicament container (50) to the support (30) of the reconstitution device (10) according to any one of claims 1 to 22, - moving the carrier (20) relative to the base (12) and / or - moving the support (30) relative to the carrier (20).
